Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
MLS000532223
Cat. No.:
OB0225LY-0069
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
MLS000532223 is a potent selective Rho family GTPases inhibitor.
Synonym:
16616-39-0; 1-(3-Nitrophenyl)-3-phenylprop-2-yn-1-one; 2-Propyn-1-one, 1-(3-nitrophenyl)-3-phenyl-; 1-(3-Nitrophenyl)-3-phenyl-2-propyn-1-one; 1-(3-Nitrophenyl)-3-phenyl-prop-2-yn-1-one
CAS No.:
16616-39-0
Compound CID:
781112
Formula:
C15H9NO3
Formula Weight:
251.24
Specification
Relative Density:
1.31 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
MLS000532223 can be used for high-throughput screening and anti-cancer drug research.
Library Information
Targets:
GTPase superfamily
Receptors:
Rac GTPase; Ras
Pathways:
MAPK; Cell cycle/Checkpoint; GPCR/G protein
Plate Number:
AOCL-1
Plate Location:
g11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 179.11 mM
